Fierce Pharma Biopharma News & Insights
Nov 4, 2024 · Fierce Pharma delivers breaking news and analysis about drug companies, the FDA and the broader pharma industry, including manufacturing, marketing and finance.
Pharma | Fierce Pharma
Oct 14, 2024 · GSK breaks up with BIO for 2025. The company opted not to renew its membership following an annual review of its trade group associations, a spokesperson said. Zoey Becker Nov 8, 2024 4:51pm.
Top 20 Pharmaceutical Companies by Revenue 2021 | FiercePharma
Mar 29, 2021 · The company generated more than $11 billion in 2020, enough to rank it above other midsize pharma companies such as Regeneron, Vertex and Alexion. And the 2021 rankings will likely bring more ...
AstraZeneca US Broadens Income Eligibility for Prescription …
Feb 8, 2012 · WILMINGTON, Del.-- (BUSINESS WIRE)-- AstraZeneca (NYSE:AZN) announced today that it broadened the income eligibility for its AZ&Me™ Prescription Savings programs to enable more people to qualify ...
The top 10 most profitable pharma companies in 2021
The six largest drugmakers by 2021 revenue—J&J, Pfizer, Roche, AbbVie, Novartis and Merck & Co.—all made the top profit list but in quite a different order.
Generic Vyvanse cleared by FDA Amid shortage | Fierce Pharma
Aug 30, 2023 · A 100-day supply of the branded drug goes for $1,305, according to Drugs.com. Meanwhile, 30 capsules are priced at around $460. Takeda's Vyvanse shortage emerged after Adderall and its generics ...
First generics to Bristol-Myers and Pfizer's Eliquis are here. But can ...
Dec 26, 2019 · As Bristol's best-selling drug before the Celgene merger—even ahead of PD-1 inhibitor Opdivo—the drug delivered $5.9 billion to the company’s top line in the first nine months of 2019.
Pfizer eyes 8 blockbuster cancer drugs in new oncology plan
Feb 29, 2024 · Pfizer fleshes out oncology strategy, targeting 8 blockbuster cancer drugs by 2030. In what CEO Albert Bourla, Ph.D., called an update to a top priority at Pfizer, the company on Thursday ...
FDA signs off on Regeneron and Sanofi's Dupixent for COPD
Sep 27, 2024 · The COPD nod will give an added boost to the already-booming sales of Dupixent, which generated $11.6 billion last year, a 33% increase from 2022. Analysts at Evercore ISI have projected that a ...
Teva launches first U.S. generic Cialis as Eli Lilly braces for loss of ...
Sep 28, 2018 · The loss of Cialis comes during a major time of transformation for Lilly. During its second-quarter earnings report in July, the company announced that it will spin off its animal health unit ...